Background: Acute respiratory distress syndrome (ARDS) is a condition that is often considered to have broad and subjective diagnostic criteria and is associated with significant mortality and morbidity. Early and accurate prediction of ARDS and related conditions such as hypoxemia and sepsis could allow timely administration of therapies, leading to improved patient outcomes. Objective: The aim of this study is to perform an exploration of how multilabel classification in the clinical setting can take advantage of the underlying dependencies between ARDS and related conditions to improve early prediction of ARDS in patients. Methods: The electronic health record data set included 40,703 patient encounters from 7 hospitals from April 20, 2018, to March 17, 2021. A recurrent neural network (RNN) was trained using data from 5 hospitals, and external validation was conducted on data from 2 hospitals. In addition to ARDS, 12 target labels for related conditions such as sepsis, hypoxemia, and COVID-19 were used to train the model to classify a total of 13 outputs. As a comparator, XGBoost models were developed for each of the 13 target labels. Model performance was assessed using the area under the receiver operating characteristic curve. Heat maps to visualize attention scores were generated to provide interpretability to the neural networks. Finally, cluster analysis was performed to identify potential phenotypic subgroups of patients with ARDS. Results: The single RNN model trained to classify 13 outputs outperformed the individual XGBoost models for ARDS prediction, achieving an area under the receiver operating characteristic curve of 0.842 on the external test sets. Models trained on an increasing number of tasks resulted in improved performance. Earlier prediction of ARDS nearly doubled the rate of in-hospital survival. Cluster analysis revealed distinct ARDS subgroups, some of which had similar mortality rates but different clinical presentations. Conclusions: The RNN model presented in this paper can be used as an early warning system to stratify patients who are at risk of developing one of the multiple risk outcomes, hence providing practitioners with the means to take early action.
Pulmonary embolism (PE) is a life-threatening condition associated with ~10% of deaths of hospitalized patients. Machine learning algorithms (MLAs) which predict the onset of pulmonary embolism (PE) could enable earlier treatment and improve patient outcomes. However, the extent to which they generalize to broader patient populations impacts their clinical utility. To conduct the first large-scale external validation of a machine learning-based PE prediction model which uses EHR data from the first three hours of a patient's hospital stay to predict the occurrence of PE within the next 10 days of the inpatient stay. This retrospective study included approximately two million adult hospital admissions across 44 medical institutions in the US from 2011 to 2017. Demographics, vital signs, and lab tests from adult inpatients at 12 institutions (n = 331,268; 3.3% PE positive) were used for training an XGBoost model. External validation of the model was conducted on patient populations from each of 32 medical institutions (total n = 1,660,715; 3.7% PE positive) without retraining. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC). Backward elimination regression was used to identify correlations between characteristics of the external validation sets and AUROC. The model performed well (AUROC = 0.87) on the 20% hold-out subset of the training set. Despite demographic differences between the 32 external validation populations (percent PE positive: min = 1.54%, max = 6.47%), without retraining, the model had excellent discrimination, with a mean AUROC of 0.88 (min = 0.79, max = 0.93). Fixing sensitivity at 0.80, the model had a mean specificity of 0.85 (min = 0.64, max = 0.93). Backward elimination regression identified a negative association (β = -0.015, p < 0.001) between the percentage of PE positive encounters and AUROC. A PE prediction model performed remarkably well across 32 different external patient populations without retraining and despite significant differences in demographic characteristics, demonstrating its generalizability and potential as a clinical decision support tool to aid PE detection and improve patient outcomes in a clinical setting.
Background: Data drift can negatively impact the performance of machine learning algorithms (MLAs) that were trained on historical data. As such, MLAs should be continuously monitored and tuned to overcome the systematic changes that occur in the distribution of data. In this paper, we study the extent of data drift and provide insights about its characteristics for sepsis onset prediction. This study will help elucidate the nature of data drift for prediction of sepsis and similar diseases. This may aid with the development of more effective patient monitoring systems that can stratify risk for dynamic disease states in hospitals. Methods: We devise a series of simulations that measure the effects of data drift in patients with sepsis. We simulate multiple scenarios in which data drift may occur, namely the change in the distribution of the predictor variables (covariate shift), the change in the statistical relationship between the predictors and the target (concept shift), and the occurrence of a major healthcare event (major event) such as the COVID-19 pandemic. We measure the impact of data drift on model performances, identify the circumstances that necessitate model retraining, and compare the effects of different retraining methodologies and model architecture on the outcomes. We present the results for two different MLAs, eXtreme Gradient Boosting (XGB) and Recurrent Neural Network (RNN). Results: Our results show that the properly retrained XGB models outperform the baseline models in all simulation scenarios, hence signifying the existence of data drift. In the major event scenario, the area under the receiver operating characteristic curve (AUROC) at the end of the simulation period is 0.811 for the baseline XGB model and 0.868 for the retrained XGB model. In the covariate shift scenario, the AUROC at the end of the simulation period for the baseline and retrained XGB models is 0.853 and 0.874 respectively. In the concept shift scenario and under the mixed labeling method, the retrained XGB models perform worse than the baseline model for most simulation steps. However, under the full relabeling method, the AUROC at the end of the simulation period for the baseline and retrained XGB models is 0.852 and 0.877 respectively. The results for the RNN models were mixed, suggesting that retraining based on a fixed network architecture may be inadequate for an RNN. We also present the results in the form of other performance metrics such as the ratio of observed to expected probabilities (calibration) and the normalized rate of positive predictive values (PPV) by prevalence, referred to as lift, at a sensitivity of 0.8. Conclusion: Our simulations reveal that retraining periods of a couple of months or using several thousand patients are likely to be adequate to monitor machine learning models that predict sepsis. This indicates that a machine learning system for sepsis prediction will probably need less infrastructure for performance monitoring and retraining compared to other applications in which data drift is more frequent and continuous. Our results also show that in the event of a concept shift, a full overhaul of the sepsis prediction model may be necessary because it indicates a discrete change in the definition of sepsis labels, and mixing the labels for the sake of incremental training may not produce the desired results.
(1) Background: Ventilator-associated pneumonia (VAP) causes high mortality among patients with respiratory disease and imposes major burdens on healthcare infrastructure. Models that use electronic health record data to predict the onset of VAP may spur earlier treatment and improve patient outcomes. We developed and studied the performance of interpretable machine learning (ML) models that predict the onset of VAP from electronic health records (EHRs); (2) Methods: We trained Logistic Regression (LR), full feature Explainable Boosting Machine (fEBM), and eXtreme Gradient Boosting (XGBoost) ML models on data from the MIMIC- III (v1.3) database. Model performance was measured by area under the receiver operating characteristic curves (AUCs). We trained a minimal-feature EBM model (mEBM) with features derived from white blood cell (WBC) counts, duration of ventilation, and Glasgow Coma Scale (GCS). Finally, model robustness was evaluated on randomly sparsified EHR datasets; (3) Results: The fEBM model outperformed the XGBoost and LR models at 24 hours post-intubation. The mEBM model maintained an AUC of 0.893. The fEBM model performance remained robust on sparsified datasets; (4) Conclusions: Our novel interpretable ML algorithm reliably predicts the onset of VAP in intubated patients. Integration of this EBM-based model into clinical practice may enable clinicians to better anticipate and prevent VAP.
During embryonic development, cells differentiate into a variety of distinct cell types and subtypes with diverse transcriptional profiles. To date, transcriptomic signatures of different cell lineages that arise during development have been only partially characterized. Here we used single-cell RNA-seq to perform transcriptomic analysis of over 20,000 cells disaggregated from the trunk region of zebrafish embryos at the 30 hpf stage. Transcriptional signatures of 27 different cell types and subtypes were identified and annotated during this analysis. This dataset will be a useful resource for many researchers in the fields of developmental and cellular biology and facilitate the understanding of molecular mechanisms that regulate cell lineage choices during development.